ARCHIVES

Vanderbilt, Jonsson Centers Win NCI SPORE Grants.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

Study of Dlurectic Use As Renal Cell Cancer Risk Gets Concept Approval

March 10, 1989

UC Davis Study Finds Patients Need Practical Information

June 28, 2002

The Lancet Oncology Issues “Expression Of Concern” Over Paper

July 23, 2010

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

January 30, 2009

NTP Committee Finds Five Test Reports Show “Limited” Evidence Of Carcinogenicity

February 27, 1981

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976